FIELD NOTES 004: Dior Spa and Miso Cod Pilates

Reporting from a hay sauna in the Dolomites, as science and culture collide - and revealing what the Upper East Side never told you about Ozempic.

Writing to you from the Dolomites, where I somehow ended up on a six-mile hike that turned into a walking meditation - with cows as my company (see photo at the end). I’ll share my recs for this place later, but one thing I’ve been loving is the hay sauna. Yes, it’s exactly what it sounds like: you sweat, you smell hay. It’s supposed to help with respiratory issues (which I don’t have), but honestly, I just like how it feels - and how it looks.

This week I’ve been leaning into the Most Days Theory by Bree Groff - the idea that you don’t have to nail your routine every single day, just most days. Instead of judging myself by hustle or output, I’m trying to measure by how well I’m actually living.

---

🔎 THIS WEEK’S DOWNLOAD

Aka things I stumbled across—some new, some just new to me.

THINGS I LIKED THIS WEEK

1. Using CHATGPT as my therapist. Link here to my exact prompt. Sometimes the right question at the right time is all you need.

2. Fifty Essays for a Brighter Future – Picked this up at the Monocle pop-up in Bolzano and have been loving it.

3. Pilates Rise on-demand classes – My current go-to on the Equinox app; perfect for a hotel gym setup.

4. Lactibiane Tolerance – My favorite probiotic. Fun fact: during COVID, Spanish doctors often prescribed it to help patients rebuild health post illness.

---

📎 ARTICLES THAT CAUGHT MY EYE

1. Dior Brings Its Spa Concept to NYC – Business of Fashion
   Dior has opened its first U.S. spa inside the Fifth Avenue flagship. Think couture meets wellness science - LED facials, lymphatic drainage, and full-body treatments positioned as high-fashion self-care.

2. Nobu Does Pilates – via X
   Nobu Hotels is adding Pilates to its wellness programming, reinforcing how luxury hospitality brands are weaving movement and recovery into their brand story alongside fine dining and design. The announcement drew a mix of fascination and skepticism online - this tweet sums it up perfectly: link.

3. Gyms Are Going Invite-Only – Business Insider / Hustle
   From NYC’s Tera Studio & Pilates Club to LA’s Heimat and $100k-a-year Dogpound, exclusive, referral-based gyms are on the rise. For millennials and Gen Z, the draw is equal parts privacy, curated community, and social capital - wellness as a status symbol

🧠 My Take: This is straight out of the original Equinox playbook—wrap health in culture, aspiration, and a touch of exclusivity so people want to show up. The difference now is speed. Luxury and wellness are converging faster than ever: couture houses are running recovery suites, hospitality brands are programming movements like they program menus, and gyms are evolving into curated lifestyle clubs (again, hello Equinox). Wellness isn’t just about how you feel anymore - it’s part of your personal brand. And the race is on to own that space.

As for Nobu Pilates? I’m not entirely sold—you can’t just plaster a name on a workout and expect it to land. But I haven’t tried it yet, so maybe I’ll eat my words (or my miso black cod).

---

🎧 PODCASTS WORTH YOUR TIME

1. The FDA Boss on the Agency’s Makeover – The Journal: A candid interview with the new FDA commissioner—a surgeon and former professor who has openly criticized the agency for being “captured” by Big Food and Big Pharma. He shares his plans for a major overhaul, from using AI to speed drug development to rethinking the outdated U.S. food pyramid, all while reshaping how an agency that regulates one-fifth of consumer spending operates.

🧠 My Take: I don’t agree with a lot that the current administration is doing, but I do think a well-placed jolt to the system can create ripple effects that last decades. Modernizing drug development timelines with AI isn’t just a tech upgrade—it’s a structural shift that could get life-saving therapies to patients faster and at lower cost. And redesigning the U.S. food pyramid (finally) has the potential to move national nutrition policy into alignment with current science, rather than outdated lobbying-driven frameworks. These are the kinds of upstream changes that, if implemented thoughtfully, can shape the health of an entire generation.

2. The Skin We’re In – TED Radio Hour
   Our skin protects us, connects us, and constantly gathers data about the world around us. This episode explores how skin shapes our sense of self and how technology could change the way we touch and feel, featuring voices from mechanical engineering, materials science, broadcasting, and literature. Guests include Katherine Kuchenbecker, Anna Maria Coclite, Lee Thomas, and Kathryn Schulz.

🧠 My Take: I love all things TED, and TED Radio Hour never disappoints. This week’s deep dive into the science and meaning of skin made me think about the growing tension between our need for human touch and the rise of AI. I believe that as technology advances, our craving for real, human connection will only intensify. But AI might also unlock new ways to bridge distance - making it possible to “touch” and “feel” someone thousands of miles away. Episodes like this push me to rethink not just the future of technology, but how it will shape our most human experiences, day by day and year by year.

---

🧬 THE SCIENCE BIT

1. Enhancing Epigenetic Age Assessment with a Multi-Clock Framework -GeroScience, Published: August 6, 2025
   This open-access paper presents “EnsembleAge,” a multi-clock model that improves the accuracy of epigenetic aging estimates by combining several clocks into one framework. It's a leap forward in measuring biological age across contexts.

   🧠 My Take: We've gone from reading a single clock to using an ensemble - like Spotify’s daily mixes, but for your age. That means more reliable feedback on how lifestyle tweaks are showing up in your biochemistry.

2. Epigenetic Aging Linked to Alzheimer’s Biomarkers in Hispanic/Latino Adults – Clinical Epigenetics, Published: August 1, 2025
   First study to connect multiple blood-based epigenetic clocks with brain disease markers—amyloid, tau, neurodegeneration, and inflammation—in Hispanic/Latino adults.

   🧠 My Take: Aging biomarkers are starting to talk to the stuff we worry about - like memory loss. It’s a shift from abstract “age number” to something that tells you about the health of your brain circuits.

---

💸 VCs, M&A, AND STRATEGY SHIFTS

• Aug 4, 2025 — Noom launches “microdose GLP‑1” program priced from $119 with medication + habits program. (GlobeNewswire)

• Aug 4, 2025 — Westin Singapore debuts “Move Well Marathon” package for SCSM participants (sleep/recovery‑oriented hospitality offering). (PR Newswire)
  Aug 4, 2025 — Mandarin Oriental rolls out “In Pursuit of Wellness” docuseries highlighting traditional healing across properties. (Mandarin Oriental)
  Aug 5, 2025 — Generous Brands completes acquisition of Health‑Ade Kombucha. (Business Wire)

• Aug 6, 2025 — BioAge Labs Q2 + business update: NLRP3 inhibitor BGE‑102 on track for Phase 1 in 2H 2025; expanded HUNT Biobank profiling. (GlobeNewswire)

• Aug 6, 2025 — Xponential Fitness names Mike Nuzzo CEO (leadership change at major boutique fitness franchisor). (Business Wire)
  Aug 7, 2025 — August Health raises $29M Series B to scale AI‑enabled senior‑living platform. (Business Wire)
  Aug 7, 2025 — InterContinental Singapore partners with NuCalm to launch a DeepSleep recovery experience. (PR Newswire)

• Aug 8, 2025 — Altos Labs appoints Joan Mannick, M.D., as CMO & head of product development (cellular rejuvenation biotech). (Fierce Biotech)
  

  🧠 My Take: This week reinforces two big themes: the science of aging is pushing forward, and GLP-1s are moving from elite secret to mass adoption. BioAge’s progress toward a Phase 1 NLRP3 inhibitor and Altos Labs’ senior leadership hire show how longevity biotech is stacking the pieces for real clinical impact. And on the tech side, AI continues to dominate health’s investment story—another week, another raise, this time with AI applied to senior care, but the playbook is the same: data in, better decisions out, scaled across populations. On the consumer front, Noom’s entry into “microdose” GLP-1 programs signals just how far these drugs have traveled—what was once a discreet Upper East Side prescription is now a nationwide wellness offering with a subscription model. The biology is advancing, the demand is exploding, and the lines between medical intervention and everyday health routine are blurring fast.

  

  “A lazy sunday”